249 related articles for article (PubMed ID: 27359072)
1. The association between angiogenic markers and fetal sex: Implications for preeclampsia research.
Andersen LB; Jørgensen JS; Herse F; Andersen MS; Christesen HT; Dechend R
J Reprod Immunol; 2016 Sep; 117():24-9. PubMed ID: 27359072
[TBL] [Abstract][Full Text] [Related]
2. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
3. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
[TBL] [Abstract][Full Text] [Related]
4. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
5. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
[TBL] [Abstract][Full Text] [Related]
9. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
10. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
Stolz M; Zeisler H; Heinzl F; Binder J; Farr A
Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274
[TBL] [Abstract][Full Text] [Related]
11. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
12. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
[TBL] [Abstract][Full Text] [Related]
13. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
Chelli D; Hamdi A; Saoudi S; Jenayah AA; Zagre A; Jguerim H; Bedis C; Sfar E
Clin Lab; 2016 Oct; 62(10):1927-1932. PubMed ID: 28164532
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia.
Binder J; Palmrich P; Pateisky P; Kalafat E; Kuessel L; Zeisler H; Munkhbaatar M; Windsperger K; Thilaganathan B; Khalil A
Hypertension; 2020 Jul; 76(1):176-183. PubMed ID: 32450740
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
[TBL] [Abstract][Full Text] [Related]
16. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic markers in pregnancies conceived through in vitro fertilization.
Lee MS; Cantonwine D; Little SE; McElrath TF; Parry SI; Lim KH; Wilkins-Haug LE
Am J Obstet Gynecol; 2015 Aug; 213(2):212.e1-8. PubMed ID: 25797229
[TBL] [Abstract][Full Text] [Related]
18. [Influences on Placental Growth Factor (PlGF) and Soluble fms-like Tyrosine Kinase-1 (sFlt-1) Concentration Levels at the Time of First Trimester Screening].
von See J; Limperger V; Pecks U; Eckmann-Scholz C
Z Geburtshilfe Neonatol; 2016 Aug; 220(4):166-72. PubMed ID: 27135751
[TBL] [Abstract][Full Text] [Related]
19. Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.
Costa RA; Hoshida MS; Alves EA; Zugaib M; Francisco RP
Hypertens Pregnancy; 2016 May; 35(2):139-49. PubMed ID: 26930132
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]